These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 25085955)

  • 1. Regenerative medicine: transforming the drug discovery and development paradigm.
    Karathanasis SK
    Cold Spring Harb Perspect Med; 2014 Aug; 4(8):. PubMed ID: 25085955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translational regenerative medicine research: essential to discovery and outcome.
    Mason C; Dunnill P
    Regen Med; 2007 May; 2(3):227-9. PubMed ID: 17511558
    [No Abstract]   [Full Text] [Related]  

  • 3. Industry updates from the field of stem cell research and regenerative medicine in February 2020.
    Ilic D; Liovic M
    Regen Med; 2020 Jun; 15(6):1689-1694. PubMed ID: 32290767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular reprogramming: a new technology frontier in pharmaceutical research.
    Brock A; Goh HT; Yang B; Lu Y; Li H; Loh YH
    Pharm Res; 2012 Jan; 29(1):35-52. PubMed ID: 22068279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modern Approaches to Acellular Therapy in Bone and Dental Regeneration.
    Ivanov AA; Kuznetsova AV; Popova OP; Danilova TI; Yanushevich OO
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines, editors, pharma and the biological paradigm shift.
    Singh AR; Singh SA
    Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploiting pluripotent stem cell technology for drug discovery, screening, safety, and toxicology assessments.
    McGivern JV; Ebert AD
    Adv Drug Deliv Rev; 2014 Apr; 69-70():170-8. PubMed ID: 24309014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug discovery through stem cell-based organoid models.
    Ranga A; Gjorevski N; Lutolf MP
    Adv Drug Deliv Rev; 2014 Apr; 69-70():19-28. PubMed ID: 24582599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of Cellular and Tissue-based Products for Retinal Regenerative Medicine].
    Osakada F
    Yakugaku Zasshi; 2017; 137(1):23-29. PubMed ID: 28049891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global challenges in stem cell research and the many roads ahead.
    Sipp D
    Neuron; 2011 May; 70(4):573-6. PubMed ID: 21609815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Big pharma screening collections: more of the same or unique libraries? The AstraZeneca-Bayer Pharma AG case.
    Kogej T; Blomberg N; Greasley PJ; Mundt S; Vainio MJ; Schamberger J; Schmidt G; Hüser J
    Drug Discov Today; 2013 Oct; 18(19-20):1014-24. PubMed ID: 23127858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecules and small molecule drugs in regenerative medicine.
    Lu B; Atala A
    Drug Discov Today; 2014 Jun; 19(6):801-8. PubMed ID: 24252867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D Cell Printing of Tissue/Organ-Mimicking Constructs for Therapeutic and Drug Testing Applications.
    Kim J; Kong JS; Han W; Kim BS; Cho DW
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embryonic stem cell application in drug discovery.
    Lou YJ; Liang XG
    Acta Pharmacol Sin; 2011 Feb; 32(2):152-9. PubMed ID: 21217770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regenerative medicine: future impact on clinical therapies and society.
    Kargul J; Laurent GJ; Irminger-Finger I
    Int J Biochem Cell Biol; 2014 Nov; 56():1. PubMed ID: 25461768
    [No Abstract]   [Full Text] [Related]  

  • 16. Translational strategies and challenges in regenerative medicine.
    Dimmeler S; Ding S; Rando TA; Trounson A
    Nat Med; 2014 Aug; 20(8):814-21. PubMed ID: 25100527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Institutional profile. The International Society for Cellular Therapy: evolving to meet the demands of the regenerative medicine industry.
    Maziarz RT; Arthurs J; Horwitz E
    Regen Med; 2011 Mar; 6(2):163-6. PubMed ID: 21391849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced pluripotent stem cells for regenerative medicine.
    Hirschi KK; Li S; Roy K
    Annu Rev Biomed Eng; 2014 Jul; 16():277-94. PubMed ID: 24905879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CellCAN: a unique enabler of regenerative medicine and cell therapy in Canada.
    Roy DC; Alarco AM; Isasi R
    Stem Cells Dev; 2014 Dec; 23 Suppl 1():24-8. PubMed ID: 25457957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecules targeting in vivo tissue regeneration.
    Längle D; Halver J; Rathmer B; Willems E; Schade D
    ACS Chem Biol; 2014 Jan; 9(1):57-71. PubMed ID: 24372447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.